Surgical Ineligibility and Long-Term Outcomes in Patients With Severe Coronary Artery Disease

Yukiko Matsumura-Nakano1, Hiroki Shiomi1, Takeshi Morimoto2

  • 1Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine.

Insights

Patients with severe coronary artery disease (CAD) ineligible for surgery who underwent percutaneous coronary intervention (PCI) had significantly worse long-term outcomes. These outcomes were worse compared to those who received PCI without surgical ineligibility and those who underwent coronary artery bypass grafting (CABG).

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Outcomes Research

Background:

  • Severe coronary artery disease (CAD) often necessitates coronary revascularization.
  • The prevalence and impact of surgical ineligibility in CAD patients undergoing revascularization are not well-defined.

Purpose of the Study:

  • To investigate the prevalence of surgical ineligibility in patients with severe CAD undergoing revascularization.
  • To evaluate the clinical effect of surgical ineligibility on long-term outcomes.

Main Methods:

  • Analysis of 3,982 patients with triple-vessel or left main disease from the CREDO-Kyoto PCI/CABG registry cohort-2.
  • Comparison of outcomes between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) groups.
  • Assessment of surgical ineligibility documented in hospital charts, primarily due to comorbidities and advanced age.

Main Results:

  • Surgical ineligibility was present in 6.5% of PCI patients.
  • Five-year cumulative incidence of death/myocardial infarction/stroke was 52.5% for PCI patients with surgical ineligibility, versus 27.6% for PCI patients without, and 24.0% for CABG patients (P<0.001).
  • Adjusted analysis showed significantly higher risks for PCI patients with surgical ineligibility (HR 1.97) and without (HR 1.37) compared to CABG patients.

Conclusions:

  • Percutaneous coronary intervention (PCI) patients with surgical ineligibility experience worse long-term outcomes in severe coronary artery disease (CAD).
  • Outcomes for PCI patients with surgical ineligibility were poorer than for PCI patients without and for coronary artery bypass grafting (CABG) patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
903
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
380
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
218
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
332
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
596
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
324